Pediatric Surgery Lab »  People »  Principal Investigators »  Michael R. Harrison, M.D.
Michael R. Harrison, M.D.

Michael R. Harrison, M.D.

Director Emeritus, Fetal Treatment Center
Division of Pediatric Surgery
Professor Emeritus of Surgery, Pediatrics, Obstetrics, Gynecology and Reproductive Sciences

Contact Information

Open Popup
  • 1961-65, Yale University, B.A.
  • 1965-69, Harvard Medical School, M.D., Medicine
  • 1969-71, Massachusetts General Hospital, Resident, Surgery
  • 1973-74, Massachusetts General Hospital, Senior Resident, Surgery
  • 1974-75, Massachusetts General Hospital, Chief Resident, Surgery
  • 1971-73, Laboratory of Immunology, National Institute of Allergy and Infectious Disease, Fellow, Allergy & Immunology (Peds)
  • 1975-76, Rikshospitalet, Fellow, Pediatric Surgery
  • 1976-78, Children's Hospital of Los Angeles, Fellow, Pediatric Surgery
  • American Board of Surgery, 1978, renewed 1988
  • American Board of Surgery, Special Competence in Pediatric Surgery, 1979, renewed 1989
  • American Board of Surgery, Surgical Critical Care, 1991
  • Fetal Treatment Center
  • Birth Defects
  • Congenital Diaphragmatic Hernia (CDH)
  • Fetal Surgery
  • Minimally Invasive Surgery
  • Pediatric Surgery
  • Developmental Biology
  • Hematopoietic Stem Cells
  • Pectus Excavatum Repair
  • World Health
  • Birth Defects
  • Minimally Invastive Surgery

Dr. Michael Harrison is Professor Emeritus of Surgery and Pediatrics and the Director Emeritus of the Fetal Treatment Center at UCSF. He graduated cum laude from Yale University and magna cum laude from Harvard Medical School. He completed his surgical training at the Massachusetts General Hospital in Boston and his pediatric surgery fellowship at Children's Hospital of Los Angeles. He is board certified in Surgery, Pediatric Surgery, and Critical Care.

Dr. Harrison and his surgery associates confine their surgical practice exclusively to children with special interest in fetal surgery, in repair of complex birth defects involving the chest, lung, abdomen, bowel, and bladder, and surgical care of children from birth through adolescence. Dr. Harrison and his associates, The Bay Area Pediatric Surgeons, do consultations and provide surgical care at Moffitt/Long Hospitals UCSF, California Pacific Medical Center, and Kaiser Permanente, San Francisco.

Dr. Harrison has a special interest in fetal surgery which he has pioneered with his colleagues at UCSF. For the past 18 years Dr. Harrison has studied the pathophysiology and natural history of a number of life-threatening fetal abnormalities including congenital diaphragmatic hernia, congenital cystic adenomatoid malformation of the lung, sacrococcygeal teratoma, fetal obstructive uropathy, and myelomeningocele. He has developed techniques for both in-utero open fetal surgery and endoscopic surgical repair (FETENDO Fetal Surgery)of many fetal abnormalities. In addition, Dr. Harrison's team has developed in-utero stem cell transplantation to treat immunodeficiencies, enzyme deficiencies, and hemoglobinopathies. Dr. Harrison leads the multidisciplinary UCSF Fetal Treatment Center Team that has developed an international reputation for treating complex birth defects before and after birth. (Referrals can be made to 1-800-RX-FETUS.)

Dr. Harrison, his wife Gretchen, and four children have lived in San Francisco for the past 20 years.

Most recent publications from a total of 453
  1. Graves CE, Co C, Hsi RS, Kwiat D, Imamura-Ching J, Harrison MR, Stoller ML. Magnetic Compression Anastomosis (Magnamosis): First-In-Human Trial. J Am Coll Surg. 2017 Aug 23. View in PubMed
  2. Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH, Gore JL, Hancock SL, Harrison MR, Kim W, Kyriakopoulos C, LaGrange C, Lam ET, Lau C, Michaelson MD, Olencki T, Pierorazio PM, Plimack ER, Redman BG, Shuch B, Somer B, Sonpavde G, Sosman J, Dwyer M, Kumar R. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Jun; 15(6):804-834. View in PubMed
  3. Moon-Grady AJ, Baschat A, Cass D, Choolani M, Copel JA, Crombleholme TM, Deprest J, Emery SP, Evans MI, Luks FI, Norton ME, Ryan G, Tsao K, Welch R, Harrison M. Fetal Treatment 2017: The Evolution of Fetal Therapy Centers - A Joint Opinion from the International Fetal Medicine and Surgical Society (IFMSS) and the North American Fetal Therapy Network (NAFTNet). Fetal Diagn Ther. 2017 May 23. View in PubMed
  4. Gopalakrishna A, Longo TA, Fantony JJ, Harrison MR, Inman BA. Physical activity patterns and associations with health-related quality of life in bladder cancer survivors. Urol Oncol. 2017 Sep; 35(9):540.e1-540.e6. View in PubMed
  5. Bhavsar NA, Harrison MR, Hirsch BR, Creel P, Wolf SP, Samsa GP, Abernethy AP, Simantov R, Borham A, George DJ. Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer. Cancer Invest. 2017 May 28; 35(5):333-344. View in PubMed
  6. Graves CE, Hirose S, Raff GW, Iqbal CW, Imamura-Ching J, Christensen D, Fechter R, Kwiat D, Harrison MR. Magnetic Mini-Mover Procedure for pectus excavatum IV: FDA sponsored multicenter trial. J Pediatr Surg. 2017 Mar 15. View in PubMed
  7. Ramalingam S, Humeniuk MS, Hu R, Rasmussen J, Healy P, Wu Y, Harrison MR, Armstrong AJ, George DJ, Zhang T. Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer. Urol Oncol. 2017 Jun; 35(6):418-424. View in PubMed
  8. Inman BA, Longo TA, Ramalingam S, Harrison MR. Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer. Clin Cancer Res. 2017 Apr 15; 23(8):1886-1890. View in PubMed
  9. Armstrong AJ, Humeniuk MS, Healy P, Szmulewitz R, Winters C, Kephart J, Harrison MR, Martinez E, Mundy K, Halabi S, George D. Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial. Prostate. 2016 Nov 16. View in PubMed
  10. Ramalingam S, Eisenberg A, Foo WC, Freedman J, Armstrong AJ, Moss LG, Harrison MR. Treatment-related neuroendocrine prostate cancer resulting in Cushing's syndrome. Int J Urol. 2016 Oct 21. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Michael R. Harrison, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X